FINWIRES · TerminalLIVE
FINWIRES

Wealth Brokers, Investment Banks Faced Uneven First-Quarter Activity, UBS Says

-- Wealth brokers and investment banks faced uneven market activity in the first quarter due to geopolitical uncertainty, UBS Securities said in client note sent Wednesday.

For the first quarter, UBS is projecting earnings per share to be down 7% quarter on quarter and up 22% annually for wealth brokers. For investment banks, the broker is looking at a 29% slump in EPS on a quarterly basis and an 11% jump year over year.

"For wealth brokers, growth was tempered by lower March market levels, though retail trading picked up on volatility," UBS analysts, including Michael Brown, wrote. "Organic growth was solid versus expectations, with the setup improving into (2026)."

Meanwhile, momentum faded for investment banks during the quarter as pipelines shrank from the year end, "with some deals likely paused pending macro clarity, creating an activity air pocket," Brown said.

Late Tuesday, the US and Iran agreed to a two-week ceasefire. The war, which began at the end of February, spread across the Middle East and curtailed shipments through the crucial Strait of Hormuz.

UBS named Charles Schwab (SCHW) and Stifel Financial (SF) as its top picks heading into the first-quarter earnings season, saying Evercore (EVR) is "favorably positioned." Moelis (MC), Lazard (LAZ), and Raymond James Financial (RJF) are expected to "lag on a relative basis," according to the brokerage.

UBS upgraded LPL Financial (LPLA) to buy, citing an attractive valuation.

UBS lowered its price targets for wealth brokers and investment banks by 8% and 2% on average, respectively.

The brokerage expects artificial intelligence to be a key topic at the upcoming earnings season for wealth brokers.

"In the wealth space, we expect AI to improve advisor productivity, though see risks to sweep cash economics and to market share of advised assets," Brown said. "Ultimately, we see these threats as slower moving than the bears think and see forward-looking firms as well positioned to adapt and thrive."

Related Articles

Research

Research Alert: Hca: Share Repurchases Help Q1 Eps Meet Estimates Despite Volume Pressures

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:HCA Healthcare delivered Q1 2026 EPS of $7.15, in line with consensus and up 10.9% Y/Y, while revenue of $19.109B grew 4.3% and beat the $19.07B consensus estimate. Same-facility admissions rose 1.3%, though surgical volumes declined with inpatient and outpatient surgeries down 0.3% and 1.7%, respectively, reflecting softness in elective procedures and seasonal headwinds. Strong share repurchase activity of $1.571B during the quarter supported EPS growth despite volume pressures. Management reaffirmed 2026 guidance ranges, indicating confidence in navigating policy headwinds. Adjusted EBITDA margin compressed 50 bps to 19.9% due to challenging volumes and inflationary cost pressures, though operating cash flow surged 22% to $2.014B. We view the continued strong cash generation and $9.179B remaining share repurchase authorization as supportive of capital returns despite headwinds from ACA enhanced premium tax credit expirations and OBBBA Medicaid funding cuts.

$HCA
Research

Research Alert: CFRA Maintains Buy Opinion On Shares Of Intel Corporation

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our target price to $100 from $75, on a P/E of 33.3x our 2028 EPS, above peers/historical to reflect our view of upside to margins/estimates. After the better than expected Q1/Q2 guide, we lift our 2026 EPS to $1.05 from $0.70, 2027 to $1.40 from $1.30, and 2028 to $3.00 from $2.64. We expect INTC's revenue trajectory to benefit from greater content share in AI servers, where the CPU-to-accelerator ratio is moving from 1:8 back toward 1:4 or potentially parity, driven by inference, agentic AI, and physical AI workloads that are more CPU-intensive. This positions the Xeon franchise for strong, sustainable demand, with a product pipeline that is ramping the fastest in five years. Within the client segment, AI PCs are now over 60% of the client CPU mix. We are also encouraged by Intel Foundry momentum amid leading-edge wafer capacity shortages, with the Elon Musk Terafab partnership and multi-year long-term agreements with Google providing major endorsements. Intel 18A process yields are tracking well.

$INTC
Research

Research Alert: CFRA Keeps Hold Rating On Shares Of Bread Financial Holdings, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price to $96 from $79, 7.8x our 2027 EPS view vs. BFH's three-year historical forward P/E average of 6.2x and the peer average of 7.1x. We increase our 2026 EPS estimate to $11.30 from $9.70 and 2027's to $12.30 from $11.62, reflecting the company's significant Q1 earnings beat and the substantial impact of an accelerated share repurchase program. A key win from Q1 was the company's return to loan growth, reversing prior-period declines with a 2% Y/Y increase in end-of-period loans. This inflection was underpinned by robust consumer activity, with credit sales accelerating to 7% growth. Furthermore, credit metrics continued their gradual improvement, with the delinquency rate falling to 5.6% and the net loss rate decreasing to 7.3%. Management prudently maintained its 2026 outlook for low single-digit growth in both average loans and revenue, with net loss rate guidance of 7.2%-7.4%, a move we believe wisely accounts for ongoing macroeconomic uncertainty and geopolitical tensions.

$BFH